Hematologic Malignancy

High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements

Hematologic11 active trials

NCIt: C131913
OncoTree: HGBCLMYCBCL2
UMLS CUI: C4524190

Clinical trials

Registered studies

16 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 9%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

No study matches these filters